Reducing the human burden of breast cancer: Advanced radiation therapy yields improved treatment outcomes

Breast Journal

Volumn 21, Issue 6, 2015, Pages 610-620

  Currey, Adam D ^a   Bergom, Carmen ^a   Kelly, Tracy R ^a   Wilson, J Frank ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

3D conformal radiation; breast cancer; intensity modulated radiation therapy; local therapy; prone breast radiation; radiation cardiac toxicity; radiation therapy

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CARDIOTOXICITY; HUMAN; META ANALYSIS (TOPIC); MORBIDITY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN TOXICITY; TREATMENT OUTCOME; ADVERSE EFFECTS; BREAST NEOPLASMS; FEMALE; HEART; PROCEDURES; RADIATION DOSE FRACTIONATION; RADIATION INJURIES; RADIATION RESPONSE; RADIOTHERAPY PLANNING SYSTEM;

BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HEART; HUMANS; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84947034762     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12495     Document Type: Article

References (110)

1. Keynes G,. Radium treatment of primary carcinoma of the breast. Lancet 1928; 212: 108-11.
2. Jones JM, Ribeiro GG,. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 1989; 40: 204-8.
3. Keynes G,. Conservative treatment of cancer of the breast. Br Med J 1937; 2: 643-66.
4. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995; 333: 1444-55.
5. Blichert-Toft M, Rose C, Andersen JA, et al,. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992; 11: 19-25.
6. van Dongen JA, Voogd AC, Fentiman IS, et al,. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst 2000; 92: 1143-50.
7. Poggi MM, Danforth DN, Sciuto LC, et al,. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. The National Cancer Institute Randomized Trial. Cancer 2003; 98: 697-702.
8. Fisher B, Anderson S, Bryant J, et al,. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41.
9. Veronesi U, Cascinelli N, Mariani L, et al,. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-32.
10. Arriagada R, Le MG, Rochard F, Contesso G,. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol 1996; 14: 1558-64.
11. Morris AD, Morris RD, Wilson JF, et al,. Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am 1997; 3: 6-12.
12. Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10801 women in 17 randomised trials. Lancet 2011; 378: 1707-16.
13. Hayman JA, Hillner BE, Harris JR, Weeks JC,. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. J Clin Oncol 1998; 16: 1022-9.
14. Bartelink H, Maingon P, Poortmans PM, et al,. Whole breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomized phase 3 trial. Lancet Oncol 2015; 16: 47-56.
15. Romestaing P, Lehingue Y, Carrie C, et al,. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997; 15: 963-8.
16. Vodue KD, Cheang MCU, Tyledesley S, et al,. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010; 28: 1684-91.
17. Hattangadi-Gluth JA, Wo JY, Nguyen PL, et al,. Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys 2012; 82: 1185-91.
18. Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ,. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat 2012; 133: 831-41.
19. Mamounas EP, Tang G, Fisher B, et al,. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol 2010; 28: 1677-83.
20. Fyles A, McCready D, Pintilie M, et al,. S2-2: luminal A subtype predicts radiation response in patients with T1N0 breast cancer enrolled in a randomized trial of tamoxifen with or without breast radiation. Cancer Res 2011; 71 (24 Suppl): S2-2.
21. Abdulkarim BS, Cuartero J, Hanson J, et al,. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol 2011; 29: 2852-8.
22. Zumsteg ZS, Morrow M, Arnold B, et al,. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Ann Surg Oncol 2013; 20: 3469-76.
23. Donker M, Litiere S, Werutsky G, et al,. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 Randomized Phase III Trial. J Clin Oncol 2013; 32: 4054-9.
24. UK Coordinating Committee on Cancer Research (UKCCCR); Ductal Carcinoma in situ (DCIS) Working Party on behalf of DCIS trialists in the UK, Australia, and New Zealand. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial. Lancet 2003; 362: 95-102.
25. Warnberg F, Garmo H, Emdin S, et al,. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial. J Clin Oncol 2014; 32: 3613-8.
26. Wapnir IL, Dignam JJ, Fisher B, et al,. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011; 103: 478-88.
27. Overgaard M, Hansen PS, Overgaard J, et al,. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949-55.
28. Overgaard M, Jensen MB, Overgaard J, et al,. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 1999; 353: 1641-8.
29. Ragaz J, Olivotto IA, Spinelli JJ, et al,. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005; 97: 116-26.
30. Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014; 383: 2127-35.
31. Whelan TJ, Olivotto IA, Parulekar WR, et al,. Regional nodal irradiation in early-stage breast cancer. NEJM 2015; 373: 307-16.
32. Poortmans PM, Collette S, Kirkove C, et al,. Internal mammary and medial supraclavicular irradiation in breast cancer. NEJM 2015; 373: 317-27.
33. Budach W, Kammers K, Boelke E, Matuschek C,. Adjuvant radiotherapy of regional lymph nodes in breast cancer-a meta-analysis of randomized trials. Radiat Oncol 2013; 8: 267-74.
34. Fisher B, Jeong J-H, Anderson S, et al,. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347: 567-75.
35. Giuliano AE, Hunt KK, Ballman KV, et al,. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. A randomized clinical trial. JAMA 2011; 305: 569-75.
36. Jagsi R, Chadha M, Moni J, et al,. Radiation field design in the ACOSOG Z0011 (alliance) trial. J Clin Oncol 2013; 32: 3600-6.
37. Donker M, van Tienhoven G, Straver ME, et al,. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomized, multicentre, open label, phase 3 non-inferiority trial. Lancet Oncol 2014; 15: 1303-10.
38. Hughes KS, Schnaper LA, Bellon JR, et al,. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 2013; 19: 2382-7.
39. McCormick B, Winter K, Hudis C, et al,. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 2015; 33: 709-15.
40. Das IJ, Cheng CW, Fein DA, Fowble B,. Patterns of dose variability in radiation prescription of breast cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 1997; 44: 83-9.
41. Buchholz TA, Gurgoze E, Bice WS, Prestidge BR,. Dosimetric analysis of intact breast irradiation in off-axis planes. Int J Radiat Oncol Biol Phys 1997; 39: 261-7.
42. Van Limbergen E, Rijnders A, van der Schueren E, Lerut T, Christiaens R,. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol J Eur Soc Ther Radiol Oncol 1989; 16: 253-67.
43. Taylor ME, Perez CA, Halverson KJ, et al,. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995; 31: 753-64.
44. Gorodetsky R, Lotan C, Piggot K, et al,. Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. Int J Radiat Oncol Biol Phys 1999; 45: 893-900.
45. Chen SA, Schuster DM, Mister D, et al,. Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 2013; 85: 309-14.
46. White J, Tai A, Arthur D, et al,. Breast cancer atlas for radiation therapy planning: consensus definitions. Radiation Therapy Oncology Group. Available at: http://www.rtog.org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx (accessed September 15, 2015).
47. Vicini FA, Sharpe M, Kestin L, et al,. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002; 54: 1336-44.
48. Sasaoka M, Futami T,. Dosimetric evaluation of whole breast radiotherapy using field-in-field technique in early-stage breast cancer. Int J Clin Oncol 2011; 16: 250-6.
49. Donovan EM, Johnson U, Shentall G, et al,. Evaluation of compensation in breast radiotherapy: a planning study using multiple static fields. Int J Radiat Oncol Biol Phys 2000; 46: 671-9.
50. Lee J-W, Hong S, Choi K-S, et al,. Performance evaluation of field-in-field technique for tangential breast irradiation. Jpn J Clin Oncol 2008; 38: 158-63.
51. Lo YC, Yasuda G, Fitzgerald TJ, Urie MM,. Intensity modulation for breast treatment using static multi-leaf collimators. Int J Radiat Oncol Biol Phys 2000; 46: 187-94.
52. Morganti AG, Cilla S, de Gaetano A, et al,. Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? J Appl Clin Med Phys 2011; 12: 213-22.
53. Mihai A, Rakovitch E, Sixel K, et al,. Inverse vs. forward breast IMRT planning. Med Dosim 2005; 30: 149-54.
54. Ahunbay EE, Chen G-P, Thatcher S, et al,. Direct aperture optimization-based intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys 2007; 67: 1248-58.
55. Van der Laan HP, Dolsma WV, Maduro JH, et al,. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 1018-23.
56. Chadha M, Woode R, Sillanpaa J, et al,. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost. Int J Radiat Oncol Biol Phys 2013; 86: 40-4.
57. Freedman GM, Anderson PR, Goldstein LJ, et al,. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 2007; 68: 347-53.
58. Formenti SC, Gidea-Addeo D, Goldberg JD, et al,. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 2007; 25: 2236-42.
59. Bantema-Joppe EJ, Schilstra C, de Bock GH, et al,. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up. Int J Radiat Oncol Biol Phys 2012; 83: e471-7.
60. McDonald MW, Godette KD, Butker EK, Davis LW, Johnstone PAS,. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis. Int J Radiat Oncol Biol Phys 2008; 72: 1031-40.
61. Harsolia A, Kestin L, Grills I, et al,. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 1375-80.
62. Freedman GM, Li T, Nicolaou N, et al,. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 2009; 74: 689-94.
63. Freedman GM, Anderson PR, Li J, et al,. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol 2006; 29: 66-70.
64. Pignol J-P, Olivotto I, Rakovitch E, et al,. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26: 2085-92.
65. Donovan E, Bleakley N, Denholm E, et al,. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007; 82: 254-64.
66. Mukesh MB, Barnett GC, Wilkinson JS, et al,. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 2013; 31: 4488-95.
67. Barnett GC, Wilkinson JS, Moody AM, et al,. Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 2012; 82: 715-23.
68. Al-Ghazal SK, Fallowfield L, Blamey RW,. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Onc 1999; 25: 571-3.
69. Moody AM, Mayles WP, Bliss JM, et al,. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol J Eur Soc Ther Radiol Oncol 1994; 33: 106-12.
70. Neal AJ, Torr M, Helyer S, Yarnold JR,. Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose-volume histograms. Radiother Oncol J Eur Soc Ther Radiol Oncol 1995; 34: 210-8.
71. Bergom C, Kelly T, Xiang Q, et al,. Prone whole breast irradiation using 3D conformal radiotherapy for breast conservation yields high rates of excellent-good cosmesis in patients with large-pendulous breasts. Int J Radiat Oncol Biol Phys 2012; 83: 821-8.
72. Mulliez T, Veldeman L, van Greveling A, et al,. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions. Radiother Oncol J Eur Soc Ther Radiol Oncol 2013; 108: 203-8.
73. Cuzick J, Stewart L, Rutqvist L, et al,. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447-53.
74. Whelan T, Julian J, Wright J, Jadad AR, Levine ML,. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis J Clin Oncol 2000; 18: 1220-9.
75. Hooning MJ, Botma A, Aleman BMP, et al,. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007; 99: 365-75.
76. Darby SC, Ewertz M, McGale P, et al,. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987-98.
77. Gagliardi G, Constine LS, Moiseenko V, et al,. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010; 76: S77-85.
78. Darby SC, Cutter DJ, Boerma M, et al,. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010; 76: 656-65.
79. Darby SC, McGale P, Taylor CW, Peto R,. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300000 women in US SEER cancer registries. Lancet Oncol 2005; 6: 557-65.
80. Hojris I, Overgaard M, Christensen JJ, Overgaard J,. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomized trials. Lancet 1999; 354: 1425-30.
81. Boekel NB, Schaapveld M, Gietema JA, et al,. Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J Natl Cancer Inst 2014; 106: 156-65.
82. Jacobson GM, Wen S, Zhang J, Hazard H, Abraham J,. Mean radiation dose to the heart in patients with breast cancer. J Clin Oncol 2013; 31 (suppl 26; abstr 56).
83. Chung E, Corbett JR, Moran JM, et al,. Is there a dose-response relationship for heart disease with low-dose radiation therapy? Int J Radiat Oncol Biol Phys 2013; 85: 959-64.
84. Bartlett FR, Colgan RM, Carr K, et al,. The UK HeartSpare Study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy. Radiother Oncol 2013; 108: 242-7.
85. Pedersen AN, Korreman S, Hystrom H, Specht L,. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol 2004; 72: 53-60.
86. Korreman SS, Pedersen AN, Aarup LR, et al,. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 2006; 65: 1375-80.
87. Korreman SS, Pedersen AN, Nottrup TJ, Specht L, Nystrom H,. Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol 2005; 76: 311-8.
88. Fernández-Lizarbe E, Montero A, Polo A, et al,. Pilot study of feasibility and dosimetric comparison of prone versus supine breast radiotherapy. Clin Transl Oncol 2013; 15: 450-9.
89. Morrow NV, Stepaniak C, White J, Wilson JF, Li XA,. Intra- and interfractional variations for prone breast irradiation: an indication for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69: 910-7.
90. Krengli M, Masini L, Caltavuturo T, et al,. Prone versus supine position for adjuvant breast radiotherapy: a prospective study in patients with pendulous breasts. Radiat Oncol Lond Engl 2013; 8: 232.
91. Formenti SC, DeWyngaert J, Jozsef G, Goldberg JD,. Prone vs supine positioning for breast cancer radiotherapy. JAMA 2012; 308: 861-3.
92. Lymberis SC, deWyngaert JK, Parhar P, et al,. Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int J Radiat Oncol Biol Phys 2012; 84: 902-9.
93. Haviland JS, Owen R, Dewar JA, et al,. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013; 14: 1086-94.
94. Owen JR, Ashton A, Bliss JM, et al,. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006; 7: 467-71.
95. Whelan TJ, Pignol J-P, Levin MN, et al,. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010; 362: 513-20.
96. Shaitelman SF, Khan AJ, Woodward WA, et al,. Shortened radiation therapy schedules for early-stage breast cancer: a review of hypofractionated whole-breast irradiation and accelerated partial breast irradiation. Breast J 2014; 20: 131-46.
97. Shaitelman SF, Buchholz TA, Hunt KK, et al,. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irradiation: results of a randomized trial. Int J Radiat Oncol Biol Phys 2014; 90: 1254.
98. Arthur DW, Vicini FA,. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 2005; 23: 1726-35.
99. Smith BD, Arthur DW, Buchholz TA, et al,. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009; 74: 987-1001.
100. Polgar C, Fodor J, Major T, Sulyok Z, Kasler M,. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 2013; 108: 197-202.
101. ® Registry Trial. Ann Surg Oncol 2012; 19: 3165-70.
102. Arthur DW, Winter K, Kuske RR, et al,. A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys 2008; 72: 467-73.
103. Vicini F, Winter K, Wong J, et al,. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys 2010; 77: 1120-7.
104. Vicini FA, Arthur DW,. Breast brachytherapy: North American experience. Semin Radiat Oncol 2005; 15: 108-15.
105. Polgar C, Strnad V, Major T,. Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol 2005; 15: 116-22.
106. Hattangadi JA, Taback N, Neville BA, Harris JR, Punglia RS,. Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance. J Natl Cancer Inst 2012; 104: 29-41.
107. Suh WW, Pierce LJ, Vicini FA, Hayman JA,. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2005; 62: 790-6.
108. Greenup RA, Camp MS, Taghian A, et al,. Cost comparison of radiation treatment options after lumpectomy for breast cancer. Ann Surg Oncol 2012; 19: 3275-81.
109. Smith BD, Bentzen SM, Correa CR, et al,. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 81: 59-68.
110. Bekelman JE, Sylwestrzak G, Barron J, et al,. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. JAMA 2014; 312: 2542-50.